Total planned funding: $475,696,200
Allocations
Countries/Regions
| Eswatini | $475,696,200 |
Organizational Types
| Private Contractor | $116,766,828 |
| Unknown | $88,328,268 |
| University | $84,194,408 |
| NGO | $82,527,974 |
| Own Agency | $56,216,683 |
| Multi-lateral Agency | $14,617,896 |
| Host Country Government Agency | $14,147,882 |
| FBO | $14,025,751 |
| Other USG Agency | $4,230,510 |
| Implementing Agency | $640,000 |
Program Areas
| Care | $142,904,821 |
| Treatment | $122,448,365 |
| Prevention | $90,139,150 |
| Governance and Systems | $52,344,868 |
| Testing | $34,069,790 |
| Management and Operations | $33,789,206 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $94,743,303 |
| HBHC: Care: Adult Care and Support | $58,553,072 |
| HKID: Care: Orphans and Vulnerable Children | $47,561,244 |
| HVCT: Testing: HIV Testing and Counseling | $34,069,790 |
| HVMS: Management and Operations | $33,789,206 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $31,569,330 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $28,910,542 |
| HVSI: Strategic Information | $26,305,677 |
| HVTB: Care: TB/HIV | $25,277,027 |
| OHSS: Health Systems Strengthening | $18,518,158 |
| HTXD: Treatment: ARV Drugs | $17,006,861 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,026,020 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,036,501 |
| PDCS: Care: Pediatric Care and Support | $11,513,478 |
| PDTX: Treatment: Pediatric Treatment | $10,698,201 |
| HLAB: Laboratory Infrastructure | $7,521,033 |
| HMBL: Biomedical Prevention: Blood Safety | $1,596,757 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$70,884,138
Countries/Regions
Not Available:
$69,868,402
Countries/Regions
Pact, Inc.:
$53,517,143
Countries/Regions
Chemonics International:
$28,867,459
Countries/Regions